These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32445443)

  • 1. Biocompatible Nanovesicular Drug Delivery Systems with Targeting Potential for Autoimmune Diseases.
    Neupane YR; Mahtab A; Siddiqui L; Singh A; Gautam N; Rabbani SA; Goel H; Talegaonkar S
    Curr Pharm Des; 2020; 26(42):5488-5502. PubMed ID: 32445443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-Based Nanovesicular Drug Delivery Systems.
    Limongi T; Susa F; Marini M; Allione M; Torre B; Pisano R; di Fabrizio E
    Nanomaterials (Basel); 2021 Dec; 11(12):. PubMed ID: 34947740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential therapeutic applications of exosomes in different autoimmune diseases.
    Xu H; Jia S; Xu H
    Clin Immunol; 2019 Aug; 205():116-124. PubMed ID: 31228581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes: Therapy delivery tools and biomarkers of diseases.
    Barile L; Vassalli G
    Pharmacol Ther; 2017 Jun; 174():63-78. PubMed ID: 28202367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of Exosomes in Targeted Drug Delivery for the Treatment of Parkinson's Disease: A Review of Recent Advances and Clinical Challenges.
    Kumar B; Pandey M; Fayaz F; Izneid TA; Pottoo FH; Manchanda S; Sharma A; Sahoo PK
    Curr Top Med Chem; 2020; 20(30):2777-2788. PubMed ID: 33076810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proniosomes: the effective and efficient drug-carrier system.
    Mittal S; Chaudhary A; Chaudhary A; Kumar A
    Ther Deliv; 2020 Feb; 11(2):125-137. PubMed ID: 31937205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases.
    Tran TH; Mattheolabakis G; Aldawsari H; Amiji M
    Clin Immunol; 2015 Sep; 160(1):46-58. PubMed ID: 25842185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Niosomes: a controlled and novel drug delivery system.
    Rajera R; Nagpal K; Singh SK; Mishra DN
    Biol Pharm Bull; 2011; 34(7):945-53. PubMed ID: 21719996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vesicles: a recently developed novel carrier for enhanced topical drug delivery.
    Akhtar N
    Curr Drug Deliv; 2014; 11(1):87-97. PubMed ID: 24533724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanovesicular carriers as alternative drug delivery systems: ethosomes in focus.
    Mbah CC; Builders PF; Attama AA
    Expert Opin Drug Deliv; 2014 Jan; 11(1):45-59. PubMed ID: 24294974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes: A new horizon in modern medicine.
    Deb A; Gupta S; Mazumder PB
    Life Sci; 2021 Jan; 264():118623. PubMed ID: 33096118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review on Different Vesicular Drug Delivery Systems (VDDSs) and Their Applications.
    Alenzi AM; Albalawi SA; Alghamdi SG; Albalawi RF; Albalawi HS; Qushawy M
    Recent Pat Nanotechnol; 2023; 17(1):18-32. PubMed ID: 35227188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosome-like Nanoparticles: A New Type of Nanocarrier.
    Fernandes M; Lopes I; Teixeira J; Botelho C; Gomes AC
    Curr Med Chem; 2020; 27(23):3888-3905. PubMed ID: 30706777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prodrugs, phospholipids and vesicular delivery - An effective triumvirate of pharmacosomes.
    Kapoor B; Gupta R; Singh SK; Gulati M; Singh S
    Adv Colloid Interface Sci; 2018 Mar; 253():35-65. PubMed ID: 29454464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes as Drug Delivery Systems: Endogenous Nanovehicles for Treatment of Systemic Lupus Erythematosus.
    Ortega A; Martinez-Arroyo O; Forner MJ; Cortes R
    Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33374908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide-directed liposomal delivery improves the therapeutic index of an immunomodulatory cytokine in controlling autoimmune arthritis.
    Meka RR; Venkatesha SH; Moudgil KD
    J Control Release; 2018 Sep; 286():279-288. PubMed ID: 30081142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposome based drug delivery as a potential treatment option for Alzheimer's disease.
    Hernandez C; Shukla S
    Neural Regen Res; 2022 Jun; 17(6):1190-1198. PubMed ID: 34782553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in lipid-based carriers for cancer therapeutics: Liposomes, exosomes and hybrid exosomes.
    Moholkar DN; Kandimalla R; Gupta RC; Aqil F
    Cancer Lett; 2023 Jul; 565():216220. PubMed ID: 37209944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances of exosomes in immune modulation and autoimmune diseases.
    Tan L; Wu H; Liu Y; Zhao M; Li D; Lu Q
    Autoimmunity; 2016 Sep; 49(6):357-365. PubMed ID: 27259064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.